Shares of CVS Group plc (LON:CVSG - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,179.64 ($15.81) and traded as high as GBX 1,234 ($16.54). CVS Group shares last traded at GBX 1,230 ($16.48), with a volume of 293,695 shares traded.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Royal Bank Of Canada restated an "outperform" rating and issued a GBX 1,500 price objective on shares of CVS Group in a research report on Friday, August 29th. Berenberg Bank reiterated a "buy" rating and set a GBX 2,000 price target on shares of CVS Group in a research report on Tuesday, September 2nd. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, CVS Group has an average rating of "Buy" and a consensus target price of GBX 1,750.
Read Our Latest Stock Report on CVSG
CVS Group Stock Performance
The stock has a market cap of £882.40 million, a PE ratio of 32,368.42, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. The business has a 50 day moving average price of GBX 1,232.88 and a two-hundred day moving average price of GBX 1,179.64.
Insider Buying and Selling at CVS Group
In related news, insider Richard Fairman acquired 1,644 shares of the company's stock in a transaction dated Friday, July 11th. The stock was purchased at an average price of GBX 1,216 per share, with a total value of £19,991.04. Company insiders own 1.38% of the company's stock.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.